H. Wallace

发表

5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity.

R. Diasio, J. Schuetz, H. Wallace, 1984, Cancer research.

A randomized, multicenter, open-label comparison of the antiemetic efficacy of dolasetron versus ondansetron for the prevention of nausea and vomiting during high-dose myeloablative chemotherapy.

R. Beveridge, R. Rifkin, A. Greenspan, 2005, Supportive cancer therapy.

Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.

P. Lin, S. Grant, D. Gewirtz, 1992, Cancer research.

Diamminodichloroplatinum in the chemotherapy of testicular tumors.

J. Holland, H. Wallace, D. Higby, 1974, The Journal of urology.

Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia.

J. Yates, J. Holland, H. Wallace, 1973, Cancer chemotherapy reports.

Mutiple myeloma resistant to melphalan (NSC-8806) treated with cyclophosphamide (NSC-26271), prednisone (NSC-10023), and chloroquine (NSC-187208).

R. Kyle, R. Silver, J. Holland, 1975, Cancer chemotherapy reports.

Comparison of the therapeutic effects of adriamycin alone versus adriamycin plus vincristine versus adriamycin plus cyclophosphamide in the treatment of advanced carcinoma of the cervix.

G. Wilbanks, W. Fowler, H. Wallace, 1978, Cancer treatment reports.

Electrocardiographic changes following adriamycin treatment.

E. Henderson, M. Barcos, H. Wallace, 1978, Medical and pediatric oncology.

Diaminodichloroplatinum: A phase I study showing responses in testicular and other tumors

J. Holland, H. Wallace, D. Higby, 1974, Cancer.

Cis-diamminedichloroplatinum (NSC-119875): a phase I study.

J. Holland, H. Wallace, D. Higby, 1973, Cancer chemotherapy reports.

Acute myelocytic leukemia.

K. Rai, H. Hoagland, J. Holland, 1976, Archives of internal medicine.

Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.

R. Diasio, J. Schuetz, J. Sommadossi, 1985, Cancer research.

Clinical and Laboratory Investigations Anderson-Fabry disease "

H. Wallace, H. J. Wallace, 2004 .

A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878).

J. Edmonson, B. Shnider, P. Burke, 1970, Cancer research.

ANDERSON-FABRY DISEASE

H. Wallace, S. Breathnach, M. Black, 1980, The Lancet.

Granular Cell Myoblastoma

H. Wallace, J. Savin, 1971, Proceedings of the Royal Society of Medicine.

Juvenile spring eruption.

H. Wallace, D. Anderson, E. Howes, 1954, Lancet.

Cutaneous moniliasis.

H. Wallace, 1955, The Practitioner.

Diseases of the hair and scalp.

H. Wallace, 1962, The Practitioner.

Thyroid screening program for irradiated population.

U. Rao, D. Shedd, H. Wallace, 1979, New York state journal of medicine.

The conservative treatment of h˦mangiomatous n˦vi

H. Wallace, 1953 .

The conservative treatment of haemangiomatous naevi.

H. Wallace, 1953, British journal of plastic surgery.

Association with Enhanced Fragmentation of Mature DNA by the Protein Kinase C Activator Bryostatin 1 in HL-60 Cells :d-Arabinofuranosylcytosine β Potentiation of the Activity of 1-Updated

P. Lin, D. Gewirtz, P. Swerdlow, 2006 .

Alteration of the secondary structure of newly synthesized DNA from murine bone marrow cells by 5-fluorouracil.

R. Diasio, J. Schuetz, J. Collins, 1986, Cancer research.

DNA repair following incorporation of 5-fluorouracil into DNA of mouse bone marrow cells

R. Diasio, J. Schuetz, H. Wallace, 1988, Cancer Chemotherapy and Pharmacology.

The Renal Lesion in Angiokeratoma Corporis Diffusum

D. Miller, M. Hutt, H. D. de Wardener, 1958, British medical journal.

Delay, stage of disease and survival from breast cancer.

R. Priore, H. Wallace, P. Reese, 1979, Journal of chronic diseases.

Leukemia-specific DNA sequences in leukocytes of the leukemic member of identical twins.

W. Baxt, S. Spiegelman, J. Yates, 1973, Proceedings of the National Academy of Sciences of the United States of America.

Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.

E. Henderson, H. Wallace, D. Higby, 1977, Cancer treatment reports.

VULVAL ATROPHY AND LEUKOPLAKIA.

H. Wallace, I. W. WHIMSTER, 1951, The British journal of dermatology.

Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children.

H. Wallace, A. Freeman, D. Higby, 1977, Cancer treatment reports.

(6) Ulcerative colitis, systemic sclerosis and necrobiosis

H. Wallace, 1974 .

The Conservative Treatment of Hemangiomatous Nevi

H. Wallace, 1953 .

Clinical evaluation of estrogen-androgen combination in advanced breast cancer.

H. Wallace, T. Hall, H. B. Nevinny, 1969, American journal of surgery.

Reduction of cis-dichlorodiammine platinum ii (ddp) toxicity by penicillamine (pn) compounds in animal models and humans. Abstr.

H. Wallace, D. Higby, J. Bekesi, 1975 .

Angiokeratoma corporis diffusum. A clinical study of eight affected families.

H. Wallace, E. Jellinek, D. Wise, 1962, The Quarterly journal of medicine.

Phase I Evaluation of cis-Platinum (II) Diamminedichloride (PDD) and a Combination of PDD Plus Adriamycin

H. Wallace, D. Higby, 1974 .

(1) Eruptive juvenile melanomata

H. Wallace, 1974 .

Carcinoembryonic antigen in osteosarcoma

G. Murphy, H. Wallace, E. Cortes, 1977, Journal of surgical oncology.

A Case of Early Yaws

C. Nicol, H. Wallace, J. Barrow, 1959, British medical journal.

Angiokeratoma corporis diffusum. A clinical study of eight affected families.

H. Wallace, E. Jellinek, D. Wise, 1962, The Quarterly journal of medicine.